Distribuzione geografica
Continente #
EU - Europa 178
NA - Nord America 143
AS - Asia 53
OC - Oceania 12
SA - Sud America 10
AF - Africa 1
Totale 397
Nazione #
US - Stati Uniti d'America 121
GB - Regno Unito 64
IT - Italia 50
CA - Canada 20
DE - Germania 20
TR - Turchia 13
AU - Australia 12
JP - Giappone 12
FR - Francia 11
BR - Brasile 7
IN - India 6
CN - Cina 5
FI - Finlandia 5
RO - Romania 4
SA - Arabia Saudita 4
AT - Austria 3
GR - Grecia 3
RU - Federazione Russa 3
SG - Singapore 3
BE - Belgio 2
CL - Cile 2
ES - Italia 2
IL - Israele 2
NL - Olanda 2
RS - Serbia 2
AM - Armenia 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SE - Svezia 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 397
Città #
London 59
San Francisco 32
Rome 22
Toronto 20
Council Bluffs 18
Redmond 16
Canberra 6
Ashburn 5
Helsinki 5
Melbourne 5
Los Angeles 4
Paris 4
Riyadh 4
São Paulo 4
Athens 3
Ningbo 3
Oklahoma City 3
Padova 3
Seelze 3
Tokyo 3
Vienna 3
Amsterdam 2
Caluire-et-Cuire 2
Charlotte 2
Ferrara di Monte Baldo 2
Haikou 2
Hyderabad 2
Kragujevac 2
New York 2
Scafati 2
Singapore 2
Amman 1
Ankara 1
Bari 1
Berlin 1
Boardman 1
Boydton 1
Brussels 1
Budapest 1
Centurion 1
Charleston 1
Chisinau 1
Costabissara 1
Dalsjoefors 1
Dorchester 1
Frankfurt am Main 1
Haifa 1
Hanover 1
Krasnoyarsk 1
Kuwait City 1
Lima 1
Lincoln 1
Macerata 1
Madrid 1
Manassas 1
Manila 1
Martignacco 1
Mexico City 1
Miami 1
Minsk 1
Morgantown 1
Paola 1
Phoenix 1
Piemonte 1
Porto 1
Prague 1
Puchong Batu Dua Belas 1
Redwood City 1
San Pietro in Lama 1
Sanaa 1
Satu Mare 1
Secaucus 1
Sydney 1
Yerevan 1
Totale 288
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 19
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 12
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 11
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 10
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 10
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 10
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 9
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 9
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 8
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 8
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 7
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma 7
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 6
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 6
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 6
Osteoporosis 2014 6
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 6
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 6
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 6
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 5
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 5
Bone Health in Cancer Patients 5
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 5
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 5
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 5
Biological effects of cabozantinib on bone microenvironment 5
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 5
Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus 5
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 5
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 5
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 5
Bone metastases in biliary cancers: A multicenter retrospective survey 4
Interventional radiologist's perspective on the management of bone metastatic disease 4
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 4
Facing SARS-CoV-2 outbreak in immunotherapy era 4
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 4
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 4
Natural history of malignant bone disease in gastric cancer: Final results of a multicenter bone metastasis survey 4
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 4
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 4
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma 4
Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey 4
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 4
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma 4
Serum Plasma Leptin Levels and Life Expectancy in Cancer Patients with Terminal Illness 4
Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting 4
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors 4
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 3
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 3
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 3
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 3
Premetastatic niche: ready for new therapeutic interventions? 3
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 3
Magnesium: are we better off without it? 3
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis 3
Current and Emerging Biomarkers Predicting Bone Metastasis Development 3
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 3
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 3
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 3
New developments of aminobisphosphonates: the double face of Janus 3
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 3
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 3
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 3
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 3
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 3
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 3
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 3
CETUXIMAB: From bench to bedside 3
Editorial: RANK/RANKL pathway in cancer: Biological activity beyond bone? 3
Targeting bone metastases: New drugs for new targets 3
Designing a broad-spectrum integrative approach for cancer prevention and treatment 3
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 3
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b) 3
Prognostic and predictive factors in pancreatic cancer 3
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 3
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 3
null 3
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 3
Circulating Tumor Cells in Soft Tissue Sarcomas Patients 3
Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients 3
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 3
Integrin a5 is an independent prognosis factor and a potential therapeutic target for breast cancer bone metastasis 3
The Role of Macrophages Polarization in Predicting Prognosis in Radically Resected Gastric Cancer 3
Anterior and posterior vaginal myomectomy: A new surgical technique 2
Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma 2
Determinants of bone specific metastasis in prostate cancer 2
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 2
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management 2
Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer 2
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 2
Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial 2
Erratum: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples (vol 39, 95, 2020) 2
Targeted therapies for bone metastases 2
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer 2
Oncologia 2
The role of bone microenvironment, vitamin D and calcium 2
Monoclonal antibodies 2
Bone-Targeted Agents 2
New molecular targets in bone metastases 2
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 2
Totale 428
Categoria #
all - tutte 16.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.381

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022332 0 0 9 1 89 4 8 1 12 1 4 203
2022/202367 2 1 0 1 6 3 7 15 2 3 24 3
2023/202491 19 50 22 0 0 0 0 0 0 0 0 0
Totale 490